Behçet's disease: An insight from a cardiologist's point of view

Open Cardiovascular Medicine Journal

Volumn 4, Issue SPEC. ISSUE 1, 2010, Pages 63-70

  Cocco, Giuseppe ^a   Gasparyan, Armen Yuri ^b  

^a Cardiology Office   (Switzerland)

^b DUDLEY GROUP OF HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Beh et's disease; Cardiovascular involvement; Diagnosis; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CARVEDILOL; CLOPIDOGREL; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIURETIC AGENT; METHOTREXATE;

ADULT; AGED; ARTICLE; BEHCET DISEASE; CARDIOVERSION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ANEURYSM; DIASTOLIC DYSFUNCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSPNEA; ELECTROCARDIOGRAPHY; EYE DISEASE; FEMALE; FIRST DEGREE ATRIOVENTRICULAR BLOCK; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MURMUR; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HUMAN; HYPERTENSION; INTRACARDIAC THROMBOSIS; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIDE EFFECT; SKIN DISEASE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SUPRAVENTRICULAR PREMATURE BEAT; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 78249276365     PISSN: None     EISSN: 18741924     Source Type: Journal    
DOI: 10.2174/1874192401004010063     Document Type: Article

References (47)

1. Gasparyan AY, Mohammad-Hasani MR, Hassoun H, Darban H. Recent advances in cardiovascular medicine: the tenth Iranian congress on cardiovascular update. Recent advances in cardiovascular medicine: the tenth Iranian congress on cardiovascular update. Arch Iran Med 2009; 12: 213-6.
2. Gasparyan AY, Ugurlucan M. The emerging issue of cardiovascular involvement in familial Mediterranean fever. Arch Med Sci 2008; 4: 465-7.
3. Koç Y, Güllü I, Akpek G, et al. Vascular involvement in Behçet's disease. J Rheumatol 1992; 19: 402-410.
4. Lê Thi Huong D, Wechsler B, Papo T, et al. Arterial lesions in Behçet's disease. A study in 25 patients. J Rheumatol 1995; 22: 2103-2113.
5. Mogulkoc N, Burgess MI, Bishop PW. Intracardiac thrombus in Behçet's disease: a systematic review. Chest 2000; 118: 479-487.
6. Hassikou H, Bono W, Bahiri R, Abir S, Benomar M, Hassouni NH. Vascular involvement in Behçet's disease. Two case reports. Joint Bone Spine 2002; 69: 416-418.
7. Ikonomidis I, Lekakis J, Stamatelopoulos K, Markomihelakis N, Kaklamanis PG, Mavrikakis M. Aortic elastic properties and left ventricular diastolic function in patients with Adamantiades-Behcet's disease. J Am Coll Cardiol 2004; 43: 1075-1081.
8. Alpagut U, Ugurlucan M, Dayioglu E. Major arterial involvement and review of Behcet's disease. Ann Vasc Surg 2007; 21: 232-239.
9. Marzban M, Mandegar MH, Karimi A, et al. Cardiac and great vessel involvement in Behcet's disease. J Card Surg 2008; 23: 765-768.
10. Cevik C, Otahbachi M, Nugent K, Jenkins LA. Coronary artery aneurysms in Behçet's disease. Cardiovasc Revasc Med 2009; 10: 128-129.
11. Jeong DS, Kim KH, Kim JS, Ahn H. Long-term experience of surgical treatment for aortic regurgitation attributable to Behçet's disease. Ann Thorac Surg 2009; 87: 1775-1782.
12. Feigenbaum A. Description of Behçet's syndrome in the Hippo-cratic third book of endemic diseases. Br J Ophthalmol 1956; 40: 355-357.
13. Keji C. Traditional chinese medicine: clinical case studies. Beijing: Foreign Languages Press & New World Press 1994.
14. Behçet H. Über rezidivierende, aphtöse, durch ein virus verursachte geschwüre am mund, am auge und an den genitalien. Dermatol Wochenschr 1937; 105: 1152-1157.
15. Tirilomis T. Some more historical notes on Adamantiades-Beçet's disease. Chest 2001; 120: 2116.
16. Zouboulis CC, Kaklamanis P. Early descriptions of Adamantiades-Behçet's disease. Ann Rheum Dis 2003; 62: 691-692.
17. James DG. Silk route disease. Postgrad Med J 1986; 62: 151-153.
18. James DG. 'Silk route disease' (Behçet's disease). West J Med 1988; 148: 433-437.
19. Koné-Paut I, Sanchez E, Le Quellec A, Manna R, Touitou I. Au-toinflammatory gene mutations in Behçet's disease. Ann Rheum Dis 2007; 66: 832-834.
20. Gül A. Behçet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 2005; 4: 81-83.
21. Ben-Chetrit E, Yazici H. Thoughts on the proposed links between Behçet's disease and familial Mediterranean fever. Clin Exp Rheu-matol 2002; 20(4 Suppl 26): 1-2.
22. Atagunduz P, Ergun T, Direskeneli H. MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol 2003; 21(4 Suppl 30): 35-37.
23. Seyahi E, Ugurlu S, Cumali R, et al. Atherosclerosis in Behçet's Syndrome. Semin Arthritis Rheum 2008; 38: 1-12.
24. Akdogan A, Calguneri M, Yavuz B, et al. Are familial Mediterra-nean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF. J Am Coll Cardiol 2006; 48: 2351-2353.
25. Verity DH, Wallace GR, Vaughan RW, Stanford MR. Behçet's disease: from Hippocrates to the third millennium. Br J Ophthalmol 2003; 87: 1175-1183.
26. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999; 341: 1284-1291.
27. Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM. Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study. Arthritis Rheum 2009; 61: 600-604.
28. Gürler A, Boyvat A, Türsen U. Clinical manifestations of Behçet's disease: an analysis of 2147 patients. Yonsei Med J 1997; 38: 423-427.
29. Azizlerli G, Köse AA, Sarica R, et al. Prevalence of Behçet's dis-ease in Istanbul, Turkey. Int J Dermatol 2003; 42: 803-806.
30. Bonfioli AA, Orefice F. Behçet's disease. Semin Ophthalmol 2005; 20: 199-206.
31. Kurokawa SM, Suzuki N. Behcet's disease. Clin Exp Med 2004; 4: 10-20.
32. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335(6897): 1078-1080.
33. Ehrlich GE. Vasculitis in Behçet's disease. Int Rev Immunol 1997; 14: 81-88.
34. Charteris DG, Champ C, Rosenthal AR, Lightman SL. Behçet's disease: activated T lymphocytes in retinal perivasculitis. Br J Oph-thalmol 1992; 76: 499-4501.
35. Haghighi AB, Sharifzad HR, Matin S, Rezaee S. The pathological presentations of neuro-Behçet disease: a case report and review of the literature. Neurologist 2007; 13: 209-214.
36. Koşar A, Oztürk M, Haznedaroǧlu IC, Karaaslan Y. Hemostatic parameters in Behçet's disease: a reappraisal. Rheumatol Int 2002; 22: 9-15.
37. Kiraz S, Ertenli I, Oztürk MA, Haznedaroǧlu IC, Celik I, Calgüneri M. Pathological haemostasis and prothrombotic state in Behçet's disease. Thromb Res 2002; 105: 125-133.
38. Atzeni F, Sarzi-Puttini P, Doria A, Boiardi L, Pipitone N, Salvarani C. Behçet's disease and cardiovascular involvement. Lupus 2005; 14: 723-726.
39. Gürgün C, Ercan E, Ceyhan C, et al. Cardiovascular involvement in Behçet's disease. Jpn Heart J 2002; 43: 389-398.
40. Candan I, Erol C, Sonel A, Akalin H. Behçet's disease: cardiac and pulmonary involvement. Eur Heart J 1986; 7: 999-1002.
41. Kingston M, Ratcliffe JR, Alltree M, Merendino KA. Aneurysm after arterial puncture in Behçet's disease. Br Med J 1979; 1: 1766-1767.
42. Lee I, Park S, Hwang I, et al. Cardiac Behçet disease presenting as aortic valvulitis/aortitis or right heart inflammatory mass: a clinico-pathologic study of 12 cases. Am J Surg Pathol 2008; 32: 390-398.
43. Hatemi G, Silman A, Bang D, et al. EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 2008; 67: 1656-1662.
44. Shek LP, Lim DL. Thalidomide in Behçet's disease. Biomed Phar-macother 2002; 56: 31-35.
45. Green J, Upjohn E, McCormack C, Zeldis J, Prince HM. Success-ful treatment of Behçet's disease with lenalidomide. Br J Dermatol 2008; 158: 197-198.
46. Menon SP, Rajkumar SV, Lacy M, Falco P, Palumbo A. Thromboembolic events with lenalidomide-based therapy for mul-tiple myeloma. Cancer 2008; 112: 1522-1528.
47. Sharma NL, Sharma VC, Mahajan VK, Shanker V, Ranjan N, Gupta M. Thalidomide: an experience in therapeutic outcome and adverse reactions. J Dermatol Treat 2007; 18: 335-340.